STATEMENT OF NEED/TARGET AUDIENCE

Prostate cancer is one of the most rapidly evolving fields in urologic oncology. Published results from clinical trials lead to the emergence of new surgical and radiation therapy techniques and therapeutic agents, along with changes in the indications for existing treatments. In order to offer optimal patient care — including the option of clinical trial participation — the practicing urologist, radiation oncologist and medical oncologist must be well informed of these advances. To bridge the gap between research and practice, Prostate Cancer Update utilizes one-on-one discussions with leading oncology investigators. By providing access to the latest research developments and expert perspectives, this CME program assists clinicians with the formulation of up-to-date clinical management strategies.

LEARNING OBJECTIVES

• Evaluate the clinical implications of emerging clinical trial data in prostate cancer screening, prevention and treatment, and incorporate these data into management strategies in the local and advanced disease settings.
• Counsel appropriately selected patients with prostate cancer about the availability of ongoing clinical trials.
• Inform patients with prostate cancer about the specific risks and benefits of local and systemic therapies.
• Provide individualized counseling to patients with prostate cancer regarding the choice and timing of endocrine therapy.
• Talk with appropriately selected patients with prostate cancer who are at high risk or have advanced disease about the risks and benefits of chemotherapy, including emerging data on taxane-based regimens.

PURPOSE OF THIS ISSUE OF PROSTATE CANCER UPDATE

The purpose of Issue 1 of Prostate Cancer Update is to provide information that helps clinicians integrate emerging clinical research data into management strategies for patients with prostate cancer.

ACCREDITATION STATEMENT

Research To Practice is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Research To Practice designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

HOW TO USE THIS CME ACTIVITY

This CME activity contains an audio component. To receive credit, the participant should listen to the CDs, review the Internet content and complete the Post-test and Educational Assessment and Credit Form located at www.ProstateCancerUpdate.com/CME. www.ProstateCancerUpdate.com contains edited comments, clinical trial schemas, graphics and references that supplement the audio program, as well as links to relevant full-text articles, abstracts, trial information and other web resources.

This program is supported by educational grants from AstraZeneca Pharmaceuticals LP and
Sanofi-Aventis.

Table of Contents

Top of Page